DESCRIPTION:
The cerebro-renal interaction - a neglected entity
Chronic kidney disease (CKD) is an established risk factor for cardiovascular diseases. Stroke, on the other hand, is not only a major player in cardiovascular disease, but it also has strong two-way relationships with CKD. Moreover, subclinical cerebral abnormalities are also associated with CKD. But despite all these connections, the cerebro-renal interaction has so far not received much attention. This book includes easily understandable reviews on brain, stroke and kidney by both experts in nephrology and neurology. Examined are underlying concepts for cerebro-renal interaction, risk of clinical and subclinical brain damage in CKD patients, primary prevention and acute/chronic management for stroke patients with CKD and end-stage kidney disease.
This book promotes not only further understanding and a multidisciplinary collaboration between nephrologists and neurologists, but it is also of interest for neurosurgeons and cardiologists.
CONTENTS:
Introduction
1. Cerebrorenal Interaction and Stroke
Underlying Concepts for Cerebrorenal Interaction
2. Inhibition of the Renin-Angiotensin-Aldosterone System for Cerebrorenal Protection
3. Obesity and Heart Failure as a Mediator of the Cerebrorenal Interaction
Risk of Clinical and Subclinical Brain Damage in Kidney Disease
4. Subclinical Cerebral Abnormalities in Chronic Kidney Disease
5. Carotid Atherosclerosis in Kidney Disease
6. Kidney Disease and Cognitive Function
7. Risk of Stroke in Kidney Disease
Primary Prevention of Stroke in Kidney Disease
8. Role of 24-Hour Blood Pressure Management in Preventing Kidney Disease and Stroke
9. Preventing Stroke and Systemic Embolism in Renal Patients with Atrial Fibrillation: Focus on Anticoagulation
Management for Stroke in Kidney Disease
10. Stroke Features and Management in Patients with Chronic Kidney Disease
11. Stroke Feature and Management in Dialysis Patients
12. Thrombolysis and Hyperacute Reperfusion Therapy for Stroke in Renal Patients
13. Antiplatelet Therapy for Preventing Stroke in Patients with Chronic Kidney Disease
